Brazil Issues Guidance For Clinical Trials Conducted During Pandemic
Requests For Studies Involving Covid 19 Products To Be Prioritized
Executive Summary
Brazil’s medicines regulator has published advice for developers on how to proceed with ongoing clinical trials and bioequivalence studies during the current COVID-19 pandemic.